Dublin-based biotech start-up Nuritas has appointed Dr George Gunn as chairman of its board of directors.
Dr Gunn joins from Novartis where he acted as head of the company’s animal health division and as a member of its global executive committee from 2004 until early last year.
Prior to this, he also served as division head for consumer health and head of corporate social responsibility at Novartis, as well as occupying senior roles at Johnson & Johnson and Pharmacia.
Nuritas’ chief executive officer Emmet Browne said: “George’s depth of experience, knowledge and wisdom, gained at the highest levels of healthcare leadership, will be a huge addition to us as we deliver on the huge potential that lies within Nuritas.”
Meanwhile, Dr Dominique Bridon and Steve Morrison have been appointed to Nuritas’ advisory board, adding expertise in strategic translational science, and food and product regulation respectively.
Dr Bridon has over 25 years of therapeutic discovery, translational research and formulation experience, which includes working in senior management roles at Ipsen and Pharmacia.
With over two decades of regulatory experience, Steve Morrison is currently the managing director of P2F and has previously served as chief operating officer for Provexis.
Founder and chief scientific officer of Nuritas Dr Nora Khaldi said: “From our first meetings it was clear that all three shared our passion for delivering life-changing ingredients.
“I am delighted that George, Dominique and Steve are joining us.”